Active neovascular AMD in 1 eye increases risk of fellow eye conversion

• Posted on: Sep 26 2019
• By: Saratoga Opthalmology
• Leave a response

This secondary analysis of data from 2 clinical trials explores whether the type of anti-VEGF agent and baseline characteristics influence fellow eye conversion to neovascular AMD.
Source: AAO

Posted in: Uncategorized